WESLEY WOODS CENTER OF EMORY UNIVERS
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.1M
- Transactions
- 484
- Companies
- 18
- Average per transaction
- $8,550
Who reported the payments
| E.r. Squibb & Sons, L.L.C. | $2,694,014 |
| Janssen Research & Development, LLC | $476,217 |
| Bristol Myers Squibb | $456,978 |
| Incyte Corporation | $411,382 |
| AstraZeneca | $25,300 |
| Cumberland Pharmaceuticals, Inc. | $14,688 |
| Taiho Oncology, Inc. | $13,556 |
| Medical Device Business Services, Inc. | $11,045 |
| Arthrex | $8,443 |
| EMD Serono, Inc. | $7,702 |
| Avanir Pharmaceuticals, Inc. | $5,525 |
| Silk Road Medical, Inc. | $4,080 |
| Siemens Medical Solutions USA, Inc. | $2,990 |
| Fujifilm Healthcare Americas Corporation | $2,194 |
| Astrazeneca UK Limited | $1,890 |
| Samsara Vision | $1,789 |
| Fujifilm Sonosite, Inc. | $197 |
| Cerner Corporation | $125 |